Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.

Nabeel KhanNadim MahmudManthankumar PatelRamaswamy SundararajanWalter Reinisch

Published in: Alimentary pharmacology & therapeutics (2023)

In a nationwide cohort of IBD patients, we found that risk of serious infections could possibly be affected by behavioural modifications due to SARS-COV-2 pandemic.

Keyphrases

sars cov
patients with inflammatory bowel disease
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
coronavirus disease
prognostic factors
cross sectional
early onset